Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGGY: Pictilisib + Paclitaxel in HR+/HER2- Breast Cancer
NCT01740336Phase 2Completed
- Sponsor
- Genentech
- Start
- Feb 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of pictilisib in breast cancer, sponsored by Genentech. Started Feb 2013; status: completed.
02
Drugs
pictilisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01740336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740336.